The radioguided 111In-pentetreotide surgery in the management of ACTH-secreting bronchial carcinoid.
暂无分享,去创建一个
A. Cesario | G. D'errico | F. Lococo | S. Margaritora | P. Granone | A Cesario | P Granone | V Porziella | F Lococo | S Cafarotti | S Margaritora | G D'Errico | S. Cafarotti | V. Porziella
[1] P. Dalino,et al. Management of occult adrenocorticotropin-secreting bronchial carcinoids: limits of endocrine testing and imaging techniques. , 2003, The Journal of clinical endocrinology and metabolism.
[2] W. Warren,et al. Neuroendocrine components of the bronchopulmonary tract: hyperplasias, dysplasias, and neoplasms. , 1983, Laboratory investigation; a journal of technical methods and pathology.
[3] K Kayser,et al. Carcinoid tumors of the lung: Immuno‐ and ligandohistochemistry, analysis of integrated optical density, syntactic structure analysis, clinical data, and prognosis of patients treated surgically , 1996, Journal of surgical oncology.
[4] L. Mansi,et al. Diagnosis and radioguided surgery with 111In-pentetreotide in a patient with paraneoplastic Cushing's syndrome due to a bronchial carcinoid. , 1997, European journal of endocrinology.
[5] M. Bramerio,et al. Use of radioguided surgery with [111In]-pentetreotide in the management of an ACTH-secreting bronchial carcinoid causing ectopic Cushing’s syndrome , 2005, Journal of endocrinological investigation.
[6] J. Shrager,et al. Bronchopulmonary carcinoid tumors associated with Cushing's syndrome: a more aggressive variant of typical carcinoid. , 1997, The Journal of thoracic and cardiovascular surgery.